arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

NewAmsterdam Pharma Company N.V.

NAMS Health Care Biotechnology: Pharmaceutical Preparations
$31.52
▼ -3.5% Today
as of Jun 7, 07:22 ET
Last 30 days +9.75% Apr 28 → Jun 05
$27.54 $30.77 $34.01 $37.25 $40.48 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$32.40
High
$33.26
Low
$30.90
Volume
$1M
Avg Vol
$1M
Mkt Cap
$4.1B
P/E (TTM)
Beta
52w High
$42.20
52w Low
$17.63
Div Yield
Shares Out
$117M

Overview

52-week range
$18
$42
57% of range
Avg surprise (last 2)
+2.1%
Avg reaction (last 2)
+7.2%
100% positive
Latest IV / EM
100%
EM ±13.8% · $30 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.06$-0.83$-0.60$-0.38$-0.15 Actual $-0.47Actual $-0.57Actual $-1.06Actual $-0.41Actual $-0.18Actual $-0.49Est $-0.45Actual $-0.15Actual $-0.61Actual $-0.40Est $-0.46 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-72M$-46M$-21M$5M$31M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.40 $-0.46 +13.0% +18.4% +12.5% earnings
Tue Sep 30, 2025Sep 2025 $-0.61 financials
Mon Jun 30, 2025Jun 2025 $-0.15 financials
Thu May 8, 2025Mar/2025 $-0.49 $-0.45 -8.9% +1.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.18 financials
Sun Jun 30, 2024Jun 2024 $-0.41 financials
Sun Mar 31, 2024Mar 2024 $-1.06 financials
Sat Sep 30, 2023Sep 2023 $-0.57 financials
Fri Jun 30, 2023Jun 2023 $-0.47 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$3M$348,000$19M$3M$29M$2M
Cost of revenue
Gross profit
Operating income$-58M$-55M$-36M$-69M$-25M$-53M
Net income$-48M$-72M$-17M$-40M$-17M$-39M
EPS (diluted)$-0.40$-0.61$-0.15$-0.34$-0.18$-0.41

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$458M$490M$538M$564M$748M$772M$423M
Inventory
Total current assets$658M$676M$732M$770M$817M$863M$438M$445M
Total assets$733M$769M$786M$815M$818M$865M$439M$447M
Long-term debt
Total liabilities$67M$86M$58M$37M$41M$107M$60M$59M
Total equity$665M$683M$728M$778M$777M$758M$379M$387M

Implied volatility — last 90 days

94%97%99%102%104% Jun 07 — IV 100% · EM ±13.8%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.